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Proteo-Transcriptomic Dynamics of 
Cellular Response to HIV-1 Infection
Monica Golumbeanu1,2, Sébastien Desfarges3,4, Céline Hernandez  5,6, Manfredo Quadroni5, 
Sylvie Rato3, Pejman Mohammadi7, Amalio Telenti7, Niko Beerenwinkel  1,2 & Angela Ciuffi  3
Throughout the HIV-1 replication cycle, complex host-pathogen interactions take place in the infected 
cell, leading to the production of new virions. The virus modulates the host cellular machinery in order 
to support its life cycle, while counteracting intracellular defense mechanisms. We investigated the 
dynamic host response to HIV-1 infection by systematically measuring transcriptomic, proteomic, 
and phosphoproteomic expression changes in infected and uninfected SupT1 CD4+ T cells at five time 
points of the viral replication process. By means of a Gaussian mixed-effects model implemented in the 
new R/Bioconductor package TMixClust, we clustered host genes based on their temporal expression 
patterns. We identified a proteo-transcriptomic gene expression signature of 388 host genes specific 
for HIV-1 replication. Comprehensive functional analyses of these genes confirmed the previously 
described roles of some of the genes and revealed novel key virus-host interactions affecting multiple 
molecular processes within the host cell, including signal transduction, metabolism, cell cycle, and 
immune system. The results of our analysis are accessible through a freely available, dedicated and user-
friendly R/Shiny application, called PEACHi2.0. This resource constitutes a catalogue of dynamic host 
responses to HIV-1 infection that provides a basis for a more comprehensive understanding of virus-
host interactions.
Upon cellular invasion of the host T-cell, the success of HIV-1 infection depends on numerous virus-host inter-
actions. During the roughly 24-hour-long replication cycle, HIV-1 enters the host cell, integrates its genome, and 
utilizes the host cellular machinery in order to produce new virions. The host genes that are utilized by the virus 
to support its lifecycle are called HIV dependency factors (HDFs)1–9. Conversely, the host cell defense system 
tries to counteract infection through innate immune cellular responses, attempting to block different stages of the 
replication cycle. The host genes involved in these defense responses are called HIV inhibitory factors (HIFs) and 
include virus-specific restriction factors10–13.
Several studies have investigated virus-host interactions and identified dependency and inhibitory factors, 
based on siRNA experiments1–5,8,9,14, proteomic assays6,7,15, and functional screens16,17. Most of these analyses were 
focused on one type of omics data, either transcriptomics or proteomics, at a single time point. Only a few studies 
investigated HIV-host interactions with a temporal resolution18–20. In order to gain a more comprehensive under-
standing of virus-host interactions over time, we explored virus-induced cellular reprogramming at multiple 
molecular levels and time points. A series of high-resolution, genome-wide measurements of the transcriptome, 
proteome, and phosphoproteome were conducted in uninfected and infected SupT1 CD4+ T cells in order to 
define the dynamic, integrated proteo-transcriptomic response of the cell to infection with an HIVeGFP vector 
and to understand the key molecular players maintaining a balance between host support for viral replication 
and host defense response to inhibit infection (Fig. 1). For this purpose, we built on previous work and used a 
well-established SupT1 experimental cellular system18.
Using a clustering approach that we implemented in the R/Bioconductor package TMixClust, we identified 
expression signatures specific to HIV-1 infection, corresponding to novel putative host factors involved in HIV 
replication. Functional analysis of these genes provided insight into how the virus modulates key host molecular 
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processes to assure completion of its replication cycle. Our results constitute a unique resource, presenting for 
the first time a temporal analysis of HIV infection jointly at three different omics levels, namely, transcriptome, 
proteome and phosphoproteome. The data and results are freely accessible through an online catalogue allowing 
users to inspect and use them for future research, available at https://peachi2.shinyapps.io/peachi2/.
Results
Analysis of HIV replication dynamics. SupT1 CD4+ T cells were either Mock-infected or infected with an 
HIVeGFP-based vector. Virus-host interactions were characterized over time by multiple time series measurements 
(Fig. 1). As described previously18, the infection conditions allowed for quasi universal infection. Through an initial 
quantitative analysis, levels of viral intermediates - early and late reverse transcription (RT) products, integrated 
viral DNA, viral translation (GFP expression), and viral particle release (p24 release) - were evaluated every 2 h 
during 24 h to ascertain successful infection and follow HIV replication cycle advancement (Fig. 2). Consistent with 
our previous analysis18, we observed a prevalence of early and late reverse transcription products corresponding 
to the reverse transcription stage peaking at ~10 h post infection. Reverse transcription was followed by the inte-
gration stage indicated by a peak of integrated viral DNA at ~18 h. Finally, emergence of viral translation and viral 
particle release during 18–24 h post infection signaled the final stage of the viral replication cycle (Fig. 2). Analysis 
of joint virus-host omics data was performed every 6 h at the transcriptome level via RNA-Seq, and at the proteome 
and phosphoproteome levels via mass spectrometry (MS), quantifying total viral RNA, protein production, and 
phosphorylation events over time (Supplementary Figs S1 and S2). The viral transcript and protein production 
measurements over time from the virus-host omics data were consistent with the quantitative analysis of HIV 
replication progression through viral intermediate measurements (Fig. 2). Precisely, a considerable increase in viral 
transcripts and protein products after 18 h was observed, delineating the final stage of the viral replication cycle.
Quantification of omics measurements in HIV- and Mock-infected SupT1 cells. RNA-Seq yielded 
on average 108 million raw sequencing reads per sample. After read trimming and quality filtering, we obtained 
an average of 102 million aligned reads per sample, including uniquely aligned reads and multimapper reads. 
In each sample, over 90% of the reads were uniquely mapped to the concatenated human plus HIV reference 
sequence (Supplementary Table S1, Supplementary Fig. S3A). The number of reads mapping to the HIV genome 
increased with time, and was significantly correlated with viral translation (Pearson correlation ρ = 0.97, Pearson 
correlation test: p = 0.03) and with viral particle release (Pearson correlation ρ = 0.99, Pearson correlation test: 
p = 0.007), consistent with HIV life cycle progression (Supplementary Fig. S3B). Following transcriptome pro-
filing and filtering, HIV versus Mock RNA expression changes at five time points were obtained for 13,057 genes 
(Supplementary File S1, Supplementary Table S2). Principal component analysis of HIV and Mock RNA-Seq 
gene expression read counts resulted in a clear separation between HIV and Mock samples, as well as a temporal 
ordering of the HIV-infected samples (Fig. 3A).
Following SILAC MS data analysis, we detected 4,947 proteins and 2,072 phosphorylation sites corresponding 
to 793 proteins (Supplementary Table S2). After processing and filtering, HIV/Mock time series protein expres-
sion profiles were obtained for 3,613 proteins and 1,111 phosphorylation sites corresponding to 590 proteins 
(Supplementary Table S2, Supplementary File S1). We observed a similar temporal ordering of the protein and 
phosphoprotein samples in a principal component analysis of the log2(HIV/Mock) protein and phosphoprotein 
ratios (Supplementary Fig. S4).
In total, 3,455 genes had measurements at both RNA (out of 13,057 transcripts, corresponding to 26.5%) and 
protein (out of 3,613 proteins, corresponding to 95.6%); 568 genes had measurements at all three levels (Fig. 3B).
Proteo-transcriptomic temporal analysis of the host cell upon HIV-1 infection. Differential 
expression analysis between Mock and HIVeGFP-infected conditions was performed initially regardless of the 
time point (cf. Methods) and resulted in 1506 differentially expressed genes, 415 differentially expressed proteins, 
Figure 1. Experimental design overview. SupT1 CD4+ T cells were cultured in a heavy (13C6-L-lysine, 
13C615N4-L-arginine) or light isotope culture medium, respectively. Cells were either Mock-infected, or 
infected with an HIV-GFP-based vector. At different time points, cells were collected for viral intermediate 
measurements and for omic (transcriptome, proteome and phosphoproteome) measurements. The dynamic 
interplay of host-HIV interactions was investigated at the three different molecular levels, aiming at identifying 
novel putative host factors modulated during HIV replication. MS: mass spectrometry.
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and 157 differentially expressed phosphorylation sites, corresponding to 125 proteins with a differential phospho-
rylation status (Supplementary Fig. S5, Supplementary File S2). Using a Gaussian mixed-effects models frame-
work, we modeled the changes in expression of the differentially expressed genes through time and clustered 
the genes at each omics level based on their temporal profiles (cf. Methods). We implemented the model in the 
dedicated R/Bioconductor package TMixClust. For each data type (RNA, protein, and phosphoprotein), stability 
and silhouette analyses indicated that the number of Gaussian model components, or clusters, that provided the 
optimal segregation with the largest average silhouette width was two (Supplementary Figs S6–S9). Further inves-
tigation of the time series behavior in each cluster revealed a global upregulation and downregulation expression 
pattern for each data type (Supplementary Fig. S10). We found 1073 upregulated and 433 downregulated genes 
at the RNA level, 206 upregulated and 209 downregulated proteins, and 24 upregulated and 133 downregulated 
phosphorylation sites corresponding to 20 and 100 unique genes, respectively (Supplementary File S3).
The results of the clustering analysis define the proteo-transcriptomic expression response patterns of host 
genes to HIV-1 infection. These patterns and their underlying data are available in an R/Shiny application provid-
ing a user-friendly querying platform, coined PEACHi2 (Patterns of Expression and Analysis of Clusters of HIV/
Host interactions v2.0), accessible at https://peachi2.shinyapps.io/peachi2/. On this platform, users can specify 
the desired proteo-transcriptomic behavior (up- or downregulation patterns at the three data levels) and retrieve 
the corresponding genes, as well as inspect the behavior of custom gene lists and download the associated data 
(Supplementary Fig. S11).
We functionally characterized the differentially expressed genes in terms of gene set enrichment in Reactome 
pathways21, as well as in a curated library of gene sets associated to HIV-related processes, available at18 
(Supplementary File S4). The enriched Reactome pathways were stratified into functional categories according 
Figure 2. HIV replication cycle progression. (Upper panel) Schematic representation of the HIV-1 
replication cycle illustrating the major steps of HIV progression. (Lower panel) Relative quantification of viral 
intermediates, transcription and protein synthesis normalized by the 24 h time point and depicting the three 
key stages of HIV life cycle: reverse transcription, integration and late phase. Viral intermediate measurements 
consist of multiple viral DNA forms, i.e. early and late reverse transcription products (early RT, late RT) as 
well as integrated viral DNA measured by qPCR, expression of the virally encoded GFP protein measured by 
FACS (geometric mean fluorescence intensity), and viral particle production measured by p24 ELISA of the 
supernatant. Total viral transcription was quantified by the RNA-Seq reads which were aligned to the HIV 
genome. Total viral protein expression was quantified by mass spectrometry.
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to the first layer of the Reactome hierarchy of pathways21. A separate category, named “HIV”, represented the 
above-mentioned library of HIV-related gene sets. The differentially expressed genes involved in these functional 
categories were further assessed according to their identified infection-specific patterns of up- and downreg-
ulation, leading to a comprehensive image of how host gene expression is modulated during HIV infection at 
multiple molecular levels (Fig. 4). We observed a pronounced upregulation response at the RNA level, for the 
most part involving signal transduction pathways, as opposed to the other two omics levels. Our data suggest 
that HIV-1 influences the signaling mechanisms of infected cells mainly by affecting expression of cell surface 
receptors, chemokine receptors, G-protein-coupled receptors, or genes involved in signaling of Rho GTPases 
(Supplementary File S5), recapitulating previous findings22–25. At the protein and phosphoprotein levels, the iden-
tified differentially expressed genes were mainly enriched in pathways describing immune system, metabolism, 
gene expression, cell cycle, and HIV-related processes (Fig. 4, Supplementary File S5).
Four genes were found differentially expressed at all three omics levels, specifically the histone gene 
HIST1H1B, cytoskeleton protein LIMA1, transcription factor TFAP4, and the uracil DNA glycosylase UNG 
(Supplementary Fig. S12). Although the exact roles of these genes throughout the HIV replication cycle are insuf-
ficiently understood, their interactions with viral genes have been reported by previous studies. With a putative 
role in adjusting nucleosome structure and chromatin organization during HIV-1 infection, HIST1H1B has been 
shown to interact with HIV proteins Gag and Tat26,27. Co-immunoprecipitation assays have identified interactions 
between LIMA1 and viral protein Tat28. Downregulation of TFAP4 at protein level observed in our data has also 
been previously reported19. Finally, it has been shown that HIV gene Vpr induces UNG degradation during HIV 
infection29,30, supporting its observed downregulation in our data.
Based on their protein up- or downregulation behavior, host genes were nominated as putative host factors 
which are modulated during HIV replication (Supplementary File S6). Table 1 and Fig. 5 summarize the observed 
proteo-transcriptomic patterns associated to these factors.
We first assessed to what extent our detected putative factors reproduce previous well-known HIV-host inter-
actions. For this reason, a list of 3,743 previously reported host genes presumably involved in HIV-1 replica-
tion was established by including reported candidates from published studies. In this list, we included genes 
reported in siRNA screens1–3,5,8,16, protein assays6,7,15, or genome-wide analyses9,31 (Supplementary Table S3, 
Supplementary File S7). We observed a statistically significant overlap between this list and our selected candidate 
factors. More precisely, 57 upregulated (29.7%) and 73 downregulated factors (37.2%), corresponding to a total of 
130 out of 388 (33.5%) candidate factors were previously reported as being involved in host cell gene expression 
modulation during HIV replication (Hypergeometric test: p < 10−47, Supplementary File S7). Among these, we 
recovered well-known, hallmark cellular genes involved in virus-host interactions, such as the surface recep-
tor CD432, the transcription regulator NFKB133, the cyclin-dependent kinase CDK934, the Vpr-binding protein 
VPRBP35, and the uracil DNA glycosylase UNG36. In addition to the previously reported factors, our time series 
proteo-transcriptomic analysis identified new genes, including DEAD-box helicases, zinc-finger proteins, and 
kinesins, potentially involved in HIV replication, that have not been described in this role before (Supplementary 
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Figure 3. Overview of the time series omics quantification of Mock and HIV-infected SupT1 cells. (A) 
Principal component analysis for HIV and Mock gene expression profiles obtained from RNA-Seq. Each data 
point corresponds to the ensemble of gene expression RNA-Seq read counts for a corresponding time point 
and condition (either Mock or HIV-infected). The time-points are indicated next to each data point, specifying 
whether the corresponding sample is a Mock (grey circles) or HIV-infected (green squares) sample. Non-
infected samples (Mock) cluster together and separate from the HIV-infected samples which are consistently 
distributed according to their time after HIV-infection. (B) Venn diagram representing the numbers of 
detected, filtered genes at RNA, protein, and phosphoprotein levels, as well as the overlap of detected genes 
between these levels.
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File S6). The PEACHi2 online resource allows retrieving all the identified candidate factors and studying their 
behavior at the three omics levels.
Enrichment analysis of the selected upregulated and downregulated host proteins revealed the functional lay-
ers of the host cellular machinery that are perturbed during HIV infection. Precisely, these proteins were found 
enriched mainly in pathways associated to HIV, metabolism, cell cycle, immune system, and gene expression 
(Supplementary Fig. S13, Supplementary File S8). Moreover, approximately 14% of the downregulated proteins 
consisted of nucleolar and ribosomal proteins involved in ribosome biogenesis. Their observed downregula-
tion behavior has also been reported in previous studies and associated to HIV mechanisms of controlling host 
protein synthesis, ultimately inducing apoptosis at late stages of viral replication37. Enriched immune responses 
differed between the two categories of factors. While upregulated proteins were enriched in pathways mainly 
consisting of major histocompatibility complex (MHC) class I and II presentation, TOLL-receptor cascades 
and cytokine signaling, downregulated proteins were enriched in pathways containing four innate immune 
genes (CNPY3, PPP2R5D, CASP2, and CD4) as well as genes involved in CD28 family co-stimulation, CTLA-4 
Figure 4. Enrichment analysis of differentially expressed genes. Differentially expressed genes identified at 
RNA, protein and phosphoprotein levels were analyzed in terms of enrichment in Reactome pathways, as well 
as in HIV-related pathways included in a separate collection. Enriched Reactome pathways were grouped 
according to the Reactome hierarchy into enriched categories, while the HIV-related pathways were assigned 
to a separate category called “HIV”. Category names are specified on the left side of the figure. Each circle size 
(Pathway count) is proportional to the number of enriched pathways included in the corresponding category. 
The color of each circle (Significance) reflects the log10 of the geometric mean of the corrected p-values for the 
pathways included in each category. Next to each circle, the barplot displays the percentages of upregulated and 
downregulated genes in the corresponding category.
Category
Proteo-transcriptomic pattern Number 
of genesRNA Protein
Upregulated
host proteins
Upregulated
Upregulated
23
Downregulated 2
No change 167
Total: 192 genes
Downregulated 
host proteins
Upregulated
Downregulated
1
Downregulated 25
No change 170
Total: 196 genes
Table 1. Proteo-transcriptomic patterns putatively associated to host factors involved in HIV replication. The 
table presents a set of defined proteo-transcriptomic dynamic patterns presumably corresponding to host genes 
that play a role in HIV replication. Each row is associated to a specific pattern and contains the number of genes 
displaying the respective behavior at RNA and protein level. The phosphoproteome measurements were not 
used for defining these patterns, as the corresponding data was presenting a high amount of missing values and 
few genes with differentially expressed phosphorylation (125 differentially phosphorylated genes, with only 22 
also differentially expressed at RNA or protein level). At the end of each category, the total number of genes is 
specified.
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inhibitory signaling, TCR signaling, and translocation of ZAP70 to the immunological synapse (Supplementary 
File S8). Regulatory changes within these pathways during HIV infection have been reported in previous studies 
as well38–41. Furthermore, the immune system gene CD4 was among the reported downregulated factors, in agree-
ment with its well-known interaction with the viral protein Nef that downregulates CD432.
The majority of genes in both factor classes exhibited differential expression behavior at the protein level but 
not at the RNA level, suggesting direct modulation of these host proteins by HIV (Fig. 5, Supplementary File S6). 
Such examples include the transcription factors TCF7 and LEF1 which were not found differentially expressed 
at the RNA level, but downregulated at the protein level. This behavior is consistent with direct inhibition at 
the protein level of the Wnt/β-catenin pathway during HIV replication, as reported previously42,43. Conversely, 
only 13% upregulated and 13.3% downregulated factors were differentially expressed at both levels (Table 1). 
Among these were four immune system genes with consistent behavior at RNA and protein levels: upregulated 
LCP2, and downregulated GNA15, KIF20A, and TRIM36. LCP2 (Lymphocyte Cytosolic Protein 2) is involved 
in TCR-mediated intracellular activation and was shown to favor HIV replication following siRNA functional 
studies1,44. Furthermore, it has been shown that the HIV envelope protein upregulates LCP245. These previously 
reported results are concordant with the observed upregulation behavior in our data, at RNA and protein levels. 
GNA15, a G protein subunit, and KIF20A, a kinesin protein, were not reported so far to be involved in the HIV 
replication cycle. In contrast, TRIM36, a tripartite family member, was shown to be downregulated by the viral 
protein Vif. However, the exact role of TRIM36 remains to be elucidated.
Time series host phosphoproteomic characterization during HIV-1 infection. We found 157 dif-
ferentially expressed phosphorylation sites between HIV- and Mock-infected conditions, corresponding to 125 
unique phosphorylated proteins (Supplementary Table S2) involved in host molecular processes such as signal 
transduction, cell cycle, metabolism, and gene expression (Fig. 4, Supplementary File S5). Out of these, 24 sites 
presented increased phosphorylation (21 unique proteins) and 133 sites were down-phosphorylated (113 unique 
proteins). Only 22 of the differentially phosphorylated proteins were also found differentially expressed at RNA 
and protein levels (Supplementary File S9).
Few studies have analyzed the host phosphoproteomic modulation during infection with HIV15,19 and little 
is known about the regulation of the host gene phosphorylation by HIV. Wojcechowskyj et al. have performed 
a phosphoproteomic screen during HIV-1 entry and have identified 175 differentially phosphorylated proteins 
and validated 37 of them through siRNA-induced depletion15. Their study brings forward and demonstrates the 
importance of serine/arginine-rich proteins for HIV-1 splicing. Our time series phosphoproteomic data recovers 
21 out of the 175 differentially phosphorylated proteins found by their analysis, with 7 of them being among the 
ones validated by their siRNA experiments (Supplementary File S9). These include serine/arginine-rich proteins 
ACIN1 (Apoptotic Chromatin Condensation Inducer 1) and PNN (Pinin).
Figure 5. Time series patterns specific to putative host factors regulated during HIV replication. Two distinct 
patterns of protein expression behavior may define candidate host factors involved in HIV replication: 192 
upregulated proteins (upper panel) and 196 downregulated proteins (lower panel). Gene expression dynamics 
of these factors differs between RNA and protein levels. Each line corresponds to a time series expression of a 
single gene at RNA and protein levels. The box plots display the gene expression distributions at each time point 
for RNA (orange) and protein (blue).
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In another study of phosphoproteome regulation during HIV infection, Greenwood et al. show that the viral 
protein Vif induces degradation of PPP2A phosphatase family members by phosphorylation19. Among the dif-
ferentially phosphorylated proteins within our time series data, we have found members PPP1R12C and PPP4R2 
of the protein phosphatase catalytic subunit, suggesting that HIV affects the family of phosphatases to a larger 
extent. With role in cytoskeleton assembly, PPP1R12C was found upregulated at protein level and downphospho-
rylated, while PPP4R2, involved in DNA repair, was found unchanged at protein level and downphosphorylated, 
with marginal downregulation at RNA level. It has been previously shown that knocking down PPP1R12C con-
strains early viral replication steps2.
The transcription factors TCF3 and TFAP4 were found differentially phosphorylated in our data. Both factors 
were phosphorylated and downregulated at the protein level. This behavior can either suggest that phosphoryla-
tion might be required for degradation of the protein, or that phosphorylation independently affects the activity 
of the protein. Downregulation and degradation of TCF3 reiterate the afore-observed inhibition at the protein 
level of the Wnt/β-catenin pathway during HIV replication through downregulation of proteins TCF7 and LEF1. 
While the phosphorylation of TCF7 and LEF1 could not be quantified due to our limit of detection, phosphoryla-
tion of TCF3 may suggest that HIV potentially inhibits the Wnt/β-catenin pathway by inducing phosphorylation 
of its members. The transcription factor AP4 (TFAP4), known to inhibit HIV transcription46, was found down-
regulated at the protein level in our data as well as by a previous proteomic analysis19. However, our data shows for 
the first time that, while TFAP4 is downregulated at the protein level during HIV infection, the phosphorylation 
status of the protein is upregulated.
The ensemble of 157 identified differentially phosphorylated proteins in our study can be retrieved and visual-
ized on the PEACHi2 platform and constitutes a useful resource for analyzing the regulation of post-transcriptional 
modifications during HIV infection. However, it remains to be determined how HIV triggers up- or downphos-
phorylation of these proteins, as well as the roles of these phosphorylated proteins within the viral replication cycle.
Discussion
Most studies investigating on a large scale how HIV influences the host cell during infection considered so far 
the cellular transcriptome at a single time point, with little attention to protein and phosphoprotein changes. 
Although very useful, these analyses do not capture virus-specific post-transcriptional cellular regulation and 
cannot identify the influence of the virus on the host cells at the protein level47. Recent development and increas-
ing resolution of proteomic technologies have led to new insights in characterizing virus-host interactions at the 
proteome and phosphoproteome level48. In the present work, we employed both transcriptome and proteome 
high-throughput screening and reported host and virus transcriptomic, proteomic, and phosphoproteomic abun-
dances in Mock- and HIVeGFP-infected T cells at consecutive time points of the viral replication cycle. Successive 
additional measurements of several viral intermediates tracing the HIV replication cycle advancement correlated 
with viral transcriptome and proteome dynamic quantification and delineated the time course and the main 
stages of the replication cycle. On the cellular host side, by clustering time series expression profiles at the three 
levels, we were able to identify host genes involved in HIV replication, based on their displayed protein upregula-
tion or downregulation expression patterns. The identified temporal patterns have been compiled into an interac-
tive resource, PEACHi2, describing the proteo-transcriptomic responses of a host immune cell to HIV infection.
Integrating proteo-transcriptomic gene expression dynamic profiles revealed 388 host genes with putative 
roles in HIV replication, corresponding to 192 upregulated host proteins and 196 downregulated host proteins. 
Over 33.5% of the identified factors have been previously reported, in support of our findings. Of note, gene 
expression changes induced by HIVeGFP could be attributed either to HIV or to GFP expression, as it was not 
possible to dissociate GFP impact in the current experimental setting. While our study recapitulated well-known 
virus-host interaction factors, such as CD4, CDK9, NFKB1, or UNG, it also revealed numerous novel factors 
which have not been described before. These new candidate factors are involved in a wide range of molecular 
processes, such as signaling, immune response, cell cycle, gene expression, or metabolism. The majority of these 
factors were not found differentially expressed at the RNA level. This may indicate, on one hand, direct induction 
or inhibition by HIV at the protein level, arguing for a multi-omics approach. On the other hand, it is possi-
ble that low changes in RNA expression for the majority of these genes, which were not considered significant 
by our analysis, may trigger stronger response at the protein level. Furthermore, noise levels, technical biases 
across omics technologies, as well as limit of detection at the protein level, may contribute to this effect. In con-
trast, HIV-mediated modulation of genes at all the three omics levels - such as for the four genes identified here, 
LIMA1, HIST1H1B, TFAP4, and UNG - may suggest a critical role of these genes in the HIV life-cycle. A quick, 
strong, and long-term response needed for these particular genes throughout the viral life-cycle could justify the 
need of such a multi-targeted strategy.
SILAC proteomic measurements presented inferior detection compared to transcriptome quantification. Only 
26.5% of the genes detected at the RNA level were also measured successfully at the protein level, and only 4% 
were quantified at all three omics levels. Furthermore, the phosphoproteomic measurements contained a large 
amount of missing values and noise, and consequently could not be used for identifying proteo-transcriptomic 
expression signatures of infection. Furthermore, because phosphoprotein measurements needed to be adjusted by 
their protein expression in order to remove an existing abundance bias in SILAC data49, a large number of phos-
phoproteins could not be assessed due to lack of quantification at the protein level. Alternatives to SILAC, such 
as tandem mass tagging (TMT), could be attractive as they may yield a better coverage and especially less miss-
ing data in time series19. Also, combining quantifications from different proteomic techniques may increase the 
number of genes detected at the proteome and phosphoproteome level, and lead to more rigorous quantifications.
Time series expression profiling of the host cell during HIV-1 infection allows describing how the host gene 
expression is modulated through time in response to viral infection and replication. Specific temporal transcrip-
tomic expression patterns associated to different stages of the replication cycle have been previously described 
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with high-resolution time series analyses18. Our data consists of short time series (5 sampled time points per 
gene), which allows detection of global up- and downregulation patterns in response to infection. However, 
due to the relatively small number of time points and increased variability, our data is not suited for a more 
fine-grained stratification of expression patterns, capable for example of distinguishing early from late differential 
regulation. A superior number of equally distant time points, such as for example the design used in18, would be 
necessary to capture these changes robustly, as they would be supported by more than one consecutive time point.
HIV can impact the host cell at multiple levels. To alter the expression of genes at different omics levels, the 
virus disposes of a multitude of strategies. For example, it can affect transcription rates of genes, target RNA or 
protein degradation directly, or modulate enzyme activity involved in post-transcriptional and post-translational 
regulation. Through a multi-omics time series analysis of the host T cell gene expression, our work broadens and 
refines the landscape of HIV-host interactions. The different temporal expression patterns of the genes may reflect 
the diverse strategies of how HIV modulates host cell content. While offering a more detailed view of the host 
response to HIV infection, the presented analysis constitutes an initial step towards understanding the correspond-
ing regulatory mechanisms. The identified host candidates require further validations and more targeted functional 
analyses in order to understand their precise role and interactions with HIV. PEACHi2 offers a reliable resource for 
investigating and selecting candidates for follow-up analyses. Finally, studying how interfering with these interac-
tions affects HIV replication success may provide new insights for developing novel treatment strategies.
Methods
Viral infection of T-cells and sample collection. A population of 500 × 106 SupT1 cells (lymphoblas-
tic T cell line) was cultured in RPMI 1640 medium with 10% (v/v) heat-inactivated fetal bovine serum (FBS) 
(Invitrogen) (Fig. 1). Isotope-labeled amino acids (13C6-L-lysine, 13C615N4-L-arginine, Cambridge Isotope 
Laboratories (CIL), Andover, MA) were included in the heavy (H) SILAC medium at 100 mg/l, while normal 
Arginine and Lysine were used in the light (L) SILAC medium. Heavy or light SILAC labeling was achieved by 
culturing the cells in the two media (H and L) for a minimum of 2 weeks to allow for at least 5 cell divisions. 
H-labeled cells were Mock infected, while the L-labeled cells were infected with an HIVeGFP/VSV-G virus at 
3 μg/106 cells. Infection (both Mock and with an HIVeGFP vector) was carried out by spinoculation for 30 min 
at 1500 g in presence of 5 μg/ml polybrene. As previously described18, this allowed reaching a quasi-universal 
infection. Cells were then washed and further incubated. The HIVeGFP viral vector used expresses GFP instead 
of the viral protein env. At multiple time points post-infection, cells were collected and processed for analysis of 
HIV life cycle progression and normalized by the 24 h time point as in18, as well as for transcriptome, proteome 
and phosphoproteome as detailed below (Supplementary File S10).
RNA-Seq. Total RNA extraction was performed at 6 h, 12 h, 18 h, 24 h, and 30 h after Mock and HIVeGFP 
infection. The Illumina TruSeq protocol was used for preparing the mRNA-Seq library and cluster generation 
(100 NT, single end), followed by high-throughput sequencing performed on the Illumina HiSeq2000 Sequencer 
at the Genomics Technology Facility of the University of Lausanne. A replicate experiment was performed for the 
24 h time point for both HIV and Mock conditions.
SILAC Mass Spectrometry Protein and Phosphoprotein experiments. At 2 h, 6 h, 12 h, 18 h and 
24 h post Mock and HIV infection, cells were lysed by pulse sonication in 8 M Urea, 50 mM Tris pH 7.5 and 
Phos-stopTM phosphatase inhibitors (Roche). Clarified heavy and light extracts were quantitated and mixed 1:1. 
Proteins were reduced by incubation with 5 mM DTT and alkylated with 20 mM iodoacetamide, then precipitated 
with trichloroacetic acid/deoxycholate. Pellets were resuspended in 8 M Urea, 50 mM Ammonium bicarbonate 
by sonication and digested with sequencing grade trypsin (1:50) overnight at 37 °C. Digests were desalted on 
Sep-Pak C18 cartridges, and lyophilized. For total proteome analysis, digests were separated into 12 subfrac-
tions by peptide isoelectric focusing as previously described50. For phosphopeptide enrichment (i.e. peptide with 
phosphorylation site as a surrogate for phosphorylation status), aliquots of 1.0 mg of unfractionated digests were 
dissolved in loading buffer (80% acetonitrile, 5% TFA, 1 M glycolic acid) and incubated with 6 mg of titanium 
dioxide beads (5 μm, GL Sciences) for 10 min. The resin was washed 3x with 500 μl loading buffer, 2x with 80% 
acetonitrile, 0.1% TFA. A second elution was performed and analyzed separately. Phosphopeptides were eluted 
with 100 μl of 1% ammonium hydroxide and the eluate was immediately acidified with 1% TFA. Peptides were 
desalted on POROS Oligo R3 beads, dried and analyzed by LC-MS/MS. Dried peptides were resuspended in 
0.1% formic acid, 2% (v/v) acetonitrile. Samples were analyzed on a hybrid linear trap LTQ-Orbitrap Velos Pro 
mass spectrometer (Thermo Fisher, Bremen, Germany) interfaced via a nanospray source to a Dionex RSLC 
3000 nanoHPLC system (Dionex, Sunnyvale, CA, USA). Peptides were separated on a reversed-phase Acclaim 
Pepmap nanocolumn (75 μm ID × 25 cm, 2.0 μm, 100 Å, Dionex) with a gradient from 5 to 45% acetonitrile 
in 0.1% formic acid in 120 min). Full MS survey scans were performed at 60,000 resolution. All survey scans 
were internally calibrated using the 445.1200 background ion mass. In data-dependent acquisition controlled by 
Xcalibur 2.1 software (Thermo Fisher), the twenty most intense multiply charged precursor ions detected in the 
full MS survey scan were selected for Collision-Induced Dissociation (CID) fragmentation in the LTQ linear trap 
with an isolation window of 3.0 m/z in multi-stage activation mode (exciting the precursor and the neutral loss 
simultaneously) and then dynamically excluded from further selection during 120 s.
Bioinformatics data analysis and statistical modeling of time series omics data. RNA-Seq data 
processing. Illumina adapter sequences were removed from RNA-Seq reads using Cutadapt v1.7.151. Reads were 
then filtered using Prinseq-lite52 which removed their poly-A and low-quality (quality score less than 6) bound-
aries and kept for further analysis only the reads longer than 30 nucleotides and with a mean quality score larger 
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than 20. The FastQC software53 was used for quality assessment of the datasets. Sequencing reads were aligned 
using STAR v2.554 to the GRCh38 Human Genome Assembly concatenated to the HIVeGFP/VSV-G HIV genome 
sequence (Supplementary File S11). A standard way to construct the concatenated human/HIV genome is to 
add HIV as an extra chromosome to the human genome. This allows for a correct and unbiased mapping of the 
reads18. The number of reads aligned to each gene was retrieved at each time point with HTSeq-count v0.5.355 
with option –inverse, using the Ensembl genome annotations for human and HIV56 (Supplementary File S12). 
The read counts per gene were normalized using the median-of-ratios method introduced with the DESeq 
tool57. Genes with average read count less than 100 reads in both conditions (HIV-infected and Mock-infected) 
were filtered out and the gene read counts were smoothened by adding a pseudo-count of 10 reads. Afterwards, 
log2(HIV/Mock) fold changes were computed for each gene at each time point (Supplementary File S1).
Normalized relative production of total HIV reads was obtained at each time point by calculating the propor-
tion of the HIV reads out of the total number of aligned reads at each corresponding time point (Supplementary 
File S10). Relative production was then obtained by adjusting the fractions to the 24 h time point.
Principal component analysis of the gene expression read counts in all the RNA-Seq samples was used to ini-
tially explore the gene expression profiles for HIV-infected and Mock-treated samples over time.
Mass Spectrometry SILAC data processing. Mass spectrometry data from protein and phosphoprotein exper-
iments were analyzed and quantified using MaxQuant v1.3.0.5 (2013 release). The human subset of the release 
2013_07 of the UNIPROTkb database was used (www.uniprot.org). A separate database was constructed, con-
taining all sequences of HIV proteins and used in parallel. Cleavage specificity was Trypsin (cleavage after K, R) 
with two missed cleavages. Initial mass tolerances were of 4.5 particles per million (ppm) (after recalibration) for 
the precursor and 0.5 Da for CID tandem mass spectra. Protein and phosphopeptide identifications were filtered 
at 1% false discovery rate (FDR) established by MaxQuant against a reversed sequence database. Common con-
taminants and hits against reverse sequences were filtered out. Light/Heavy (L/H) ratios were normalized and the 
log2(HIV/Mock) fold changes at all time points were calculated. Only proteins with measurements supported by 
more than 2 peptides at a minimum of two consecutive time points were considered for further analysis. As sug-
gested in49, the phosphoprotein ratios were normalized by their corresponding protein ratios in order to remove 
the bias in the phosphoprotein measurements introduced by the protein relative abundance. Therefore, only 
phosphoproteins with available protein measurements were considered for the analysis. Principal component 
analysis was used to explore the profiles of log2(HIV/Mock) ratios at protein and phosphoprotein levels over time.
Normalized relative production of total HIV protein expression was calculated using the intensity-based abso-
lute quantification (IBAQ)58 retrieved from the SILAC MS experiment for the viral proteins. At each time point, 
total HIV protein IBAQ expression was divided by the total IBAQ expression from all the proteins, in order to 
obtain the fraction of the proteome constituted by the HIV proteins (S10 File). The fractions at each time point 
were further adjusted by the last time point, resulting in relative production of total HIV protein over time.
Differential expression analysis. An approach based on the distribution of relative expression changes between 
conditions(HIV-infected and Mock) as described in59 was employed for differential expression analysis. 
Accordingly, a z-score threshold of 2 standard deviations was applied to the distribution of gene log2(HIV/Mock) 
fold changes at each level (RNA, protein, and phosphoprotein) and time point. A gene was considered differen-
tially expressed between Mock and HIV-infected conditions if, at least at one time point, its log2(HIV/Mock) fold 
change was at least two standard deviations beyond the mean of the fold changes at the corresponding time point, 
i.e., had an absolute z-score greater than 2 at least at one time point (Supplementary Fig. S5).
Gaussian mixed-effects model for identifying time series gene expression patterns. Based on their log2(HIV/
Mock) time series profiles, differentially expressed genes were clustered using a Gaussian mixed-effects model 
as introduced in60 (see the Supplementary Information for a detailed description of the model). The clustering 
model was implemented in the R/Bioconductor package TMixClust and is available at https://bioconductor.org/
packages/release/bioc/html/TMixClust.html. Of note, we could not assess the variability of individual time point 
measurements due to the limited number of replicates. However, since measurements at consecutive time points 
are considered to be correlated, an increased number of time points is usually preferred over the availability of 
replicates61. Our statistical model is designed to capture smoothness of expression between time points and time 
series with highly variable behavior between consecutive time points would yield an unstable clustering result and 
would consequently be discarded.
We repeated the clustering procedure 50 times in order to avoid local optima and to identify the clustering 
configuration with the highest likelihood. We employed the distribution of the Rand index62 for the 50 separate 
clustering runs, quantifying the agreement between the different clustering solutions and the solution with the 
highest likelihood, in order to assess the stability of the clustering. After stability analysis for different numbers 
of clusters K = 1, …, 5, the distribution of the silhouette coefficient (or silhouette width)63 for each number of 
clusters was used to select the number of clusters that best fits the data. More precisely, the number of clusters that 
resulted in a clustering configuration with the largest average silhouette width was chosen.
Clustering analysis with TMixClust was applied to the time series observations of the differentially expressed 
genes at each data level (RNA, protein and phosphoprotein) separately. We characterized the overall temporal gene 
expression pattern of each resulting cluster per data type by comparing, for the ensemble of genes in each cluster, the 
distribution of their HIV/Mock expression throughout time to the baseline. An upregulated behavior was defined 
if the average temporal expression profile of the genes in a cluster was increasing and above the baseline, while a 
downregulation behavior corresponded to an average temporal expression profile of the genes in a cluster which was 
decreasing and below the baseline (Supplementary Fig. S10). The results of the clustering analysis were organized 
and made available through the PEACHi v2.0 R/Shiny resource available at https://peachi2.shinyapps.io/peachi2/.
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Enrichment analysis. Enrichment analysis was performed using the Reactome pathways21, downloaded from 
MSigDB64, and a set of manually curated HIV-specific gene sets published in18. For each gene set, enrichment was 
tested through a hypergeometric test with Benjamini-Hochberg correction for multiple testing and a significance 
threshold for the corrected p-values of 0.05. The background gene list for the enrichment tests consisted of the 
ensemble of 47,339 overall expressed genes at least at one level (RNA, protein or phosphoprotein). The hierarchi-
cal structure of the Reactome pathways21 was used to assign enriched gene sets to major functional categories and 
to construct an enrichment summary.
Data Availability
The raw RNA-Seq time series data have been deposited in NCBI’s Gene Expression Omnibus65 and are acces-
sible through GEO Series accession number GSE100587 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?ac-
c=GSE100587). The raw proteomic and phosphoproteomic data have been deposited on the ProteomeXchange 
database66 on the PRIDE repository67 and are accessible through the accession number PXD005810. The source 
code and user manual for the Bioconductor package TMixClust is available at https://bioconductor.org/packages/
release/bioc/html/TMixClust.html. The source code and data of the PEACHi2 R/Shiny resource is available on 
GitHub at https://github.com/cbg-ethz/PEACHi2.
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